IDEAYA Biosciences (IDYA) Times Interest Earned (2018 - 2026)
IDEAYA Biosciences (IDYA) posted Times Interest Earned of -$0.89 for Q1 2026, down 100.28% sequentially from $315.23 in Q4 2025, and up 89.92% YoY from -$0.47 in Q1 2025.
IDEAYA Biosciences (IDYA) Times Interest Earned (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has reported Times Interest Earned for 9 years, with the latest figure at -$0.89 in Q1 2026.
- Quarterly Times Interest Earned rose 89.92% year-over-year to -$0.89 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.51 (up 96.01% YoY) and the FY2025 annual result came in at -$0.81, up 59.1% from the prior year.
- Times Interest Earned slipped to -$0.89 in Q1 2026 per IDYA's latest filing, from $315.23 in the prior quarter.
- Over five years, Times Interest Earned peaked at $315.23 in Q4 2025 and troughed at -$1888.8 in Q4 2022.
- A 5-year average of -$106.07 and a median of -$1.56 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2025: Times Interest Earned slumped 121473.87% in 2023, then surged 249.48% in 2025.
- Over 5 years, Times Interest Earned stood at -$1888.8 in 2022, then soared by 101.55% to $29.29 in 2023, then slumped by 103.14% to -$0.92 in 2024, then surged by 34350.46% to $315.23 in 2025, then slumped by 100.28% to -$0.89 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$0.89, $315.23, and $1.38 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | IDEAYA Biosciences | 3.50 Bn | 2.67 Bn | - | -0.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.74 |
| Mar 31, 2026 | -0.89 |
| Dec 31, 2025 | 315.23 |
| Sep 30, 2025 | 1.38 |
| Jun 30, 2025 | -1.91 |
| Mar 31, 2025 | -8.86 |
| Sep 30, 2024 | -0.92 |
| Jun 30, 2024 | -0.68 |
| Mar 31, 2024 | -49.24 |
| Dec 31, 2023 | 29.29 |
| Sep 30, 2023 | -43.37 |
| Jun 30, 2023 | -27.35 |
| Mar 31, 2023 | -17.93 |
| Dec 31, 2022 | -1,888.79 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | -1.54 |
| Mar 31, 2022 | -1.58 |
| Dec 31, 2021 | -9.96 |
| Sep 30, 2021 | -172.25 |
| Jun 30, 2021 | -690.69 |